Tigermed (03347.HK): As of the end of July, a total of 20.963 million A shares have been repurchased.

Zhitong Finance APP reported that Tiger Pharmaceutical (03347.HK) announced that as of July 31, 2026, the company repurchased 20.963 million shares through a special securities account for share buybacks using centralized bidding transactions, accounting for 2.4347% of the company's total share capital and 2.8410% of the total share capital of its A shares. The highest transaction price was 42.78 yuan per share, the lowest transaction price was 38.22 yuan per share, and the total transaction amount was 824 million yuan (excluding transaction fees).